Immunology

Hsp60 Alters Development of Chlamydial Ocular Disease

Published in Vaccine Weekly, August 14th, 1995

Immunization with Hsp60 was found to alter the development of chlamydial disease in a study from the University of Arkansas.

It has been well documented in the human and in the primate that trachoma results primarily from an immunopathologic response to repeated or chronic infection with Chlamydia trachomatis.

Although the use of a whole elementary body vaccine for trachoma is not endorse, it is of interest to determine those chlamydial components responsible for eliciting the pathologic response. By definition, these may not be the optimal components of a vaccine and should be deleted from a potential vaccine.

"At least...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-08-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry